New York Life Investment Management’s Cabot Corp CBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,983
Closed -$367K 936
2024
Q1
$367K Sell
3,983
-523
-12% -$42.5K ﹤0.01% 1046
2023
Q4
$376K Sell
4,506
-140
-3% -$10.4K ﹤0.01% 1048
2023
Q3
$322K Sell
4,646
-735
-14% -$51.1K ﹤0.01% 1085
2023
Q2
$360K Sell
5,381
-856
-14% -$61K ﹤0.01% 1140
2023
Q1
$478K Sell
6,237
-2,056
-25% -$154K 0.01% 942
2022
Q4
$554K Buy
8,293
+890
+12% +$62.1K 0.01% 845
2022
Q3
$473K Buy
7,403
+586
+9% +$41.3K 0.01% 790
2022
Q2
$435K Buy
+6,817
New +$466K 0.01% 839

Other funds holding CBT

New York Life Investment Management's CBT Position: Q2 2024 in Review

New York Life Investment Management sold out of Cabot Corp (CBT) in Q2 2024, closing a stake of 3,983 shares — an estimated $367K sold.

New York Life Investment Management first reported a position in CBT in Q2 2022 and held it in 8 quarters. The position peaked at $554K in Q4 2022. 387 funds tracked by Wall St. Rank hold CBT as of Q2 2024.

  • New York Life Investment Management reported no remaining Cabot Corp position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 3,983 Cabot Corp shares in Q2 2024, an estimated $367K.
  • New York Life Investment Management first reported a position in Cabot Corp in Q2 2022 and held it in 8 quarters.
  • New York Life Investment Management's Cabot Corp position peaked at $554K in Q4 2022.
  • 387 funds tracked by Wall St. Rank held Cabot Corp as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.